Table 2.
ALCnadir% | PLTnadir% | |||
---|---|---|---|---|
BMact | BMtot | BMact | BMtot | |
p-value | p-value | p-value | p-value | |
V5 | 0.001* | 0.001* | 0.028* | 0.049* |
V10 | 0.003* | 0.002* | 0.022* | 0.044* |
V15 | 0.005* | 0.003* | 0.026* | 0.06 |
V20 | 0.008* | 0.023* | 0.044* | 0.121 |
V25 | 0.012* | 0.071 | 0.1 | 0.226 |
V30 | 0.022* | 0.121 | 0.161 | 0.265 |
V35 | 0.097 | 0.325 | 0.339 | 0.401 |
V40 | 0.216 | 0.333 | 0.289 | 0.306 |
V45 | 0.685 | 0.731 | 0.427 | 0.494 |
*Statistically significant p-value, ALCnadir% lymphocyte nadir (in percentages), PLTnadir% platelet nadir (in percentages), BMact bone marrow active, BMtot bone marrow total, V5-V45 volume (in percentages) receiving radiation dose of 5–45 Grey, respectively